Affiliation:
1. Samarth Institute of Pharmacy, Pune, Maharashtra, India
Abstract
Inflammation is still a major factor in the majority of diseases and physiological imbalances. Acute inflammation is a protective mechanism used by the immune system to remove the source of inflammation, and failure to resolve it leads to chronic inflammation. In other words, inflammation is a cleansing process that helps to maintain homeostasis by removing invading materials and noxious alterations. Serratiopeptidase, a proteolytic enzyme from the trypsin family, has a wide range of applications in the fight against inflammation. Nonsteroidal anti-inflammatory medicines (NSAIDs) are the most commonly used treatments to treat acute inflammation, either alone or in combination with other medications. These medications have a number of drawbacks, including side effects, adverse drug reactions, and so on. Enzyme-based anti-inflammatory medications have become more popular than chemical-based anti-inflammatory drugs as a result of these limitations and consequences
Reference45 articles.
1. K.D. Rainsford, Anti-inflammatory drugs in the 21st century, Subcell Biochem, 42 (2007), pp. 3-27
2. A. Bertolini, A. Ottani, M. Sandrini, Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks, Curr Med Chem, 9 (10) (2002), pp. 1033-1043
3. S. Steiger, J.L. Harper, Mechanisms of spontaneous resolution of acute gouty inflammation, Curr Rheumatol Rep, 16 (1) (2014), p. 392
4. K.K. Joshi, R.P. Nerurkar, Anti-inflammatory effect of the serratiopeptidase–rationale or fashionable: a study in rat paw edema model induced by the carrageenan, Indian J Physiol Pharmacol, 56 (4) (2012), pp. 367-374
5. P.C. Malshe, orally administered serratiopeptidase: can it work? J Assoc Physicians India, 46 (5) (1998), p. 492